NSE – NIFTY 750 | Aurobindo Pharma Limited | 17 Mar 2026Aurobindo Pharma LtdNSE:AUROPHARMAkacrajPart of the ongoing NIFTY 750 Structural Census, a long-term structural observation of Indian equities. Structure assessed from earliest reliable data. Aurobindo Pharma experienced a sharp structural expansion between 2012 and 2015 following a prolonged consolidation phase. Following the completion of this impulsive move and a subsequent correction, the long-term structure transitioned away from sustained directional behaviour. Currently, price appears to be exhibiting complex range behaviour within a broader consolidation structure. Disclaimer This analysis is part of a long-term structural study and is not intended as trading or investment advice. #NF750Census #MarketStructure #StructuralAnalysis #AurobindoPharma #EwavesJournal